Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kris Huygen

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Vaccines|May 13, 2016
A Belgian Serosurveillance/Seroprevalence Study of Diphtheria, Tetanus and Pertussis Using a Luminex xMAP Technology-Based PentaplexRaissa Nadège Caboré, Denis Piérard, Kris Huygen
Immunogenetics|May 29, 2007
Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12Youssef Fikri, Jean Nyabenda, Jean Content, et al.
Vaccine|September 20, 2005
Evaluation of the immunogenicity of pBudCE4.1 plasmids encoding mycolyl-transferase Ag85A and phosphate transport receptor PstS-3 from Mycobacterium tuberculosisMarta Romano, Virginie Roupie, Marie Hamard, et al.
Annals of the New York Academy of Sciences|January 3, 2006
Novel bacterial delivery system with attenuated Salmonella typhimurium carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse modelShreemanta K Parida, Kris Huygen, Bernhard Ryffel, et al.
Infection and Immunity|February 28, 2007
A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in miceAudrey Tanghe, Pierre-Yves Adnet, Tatiana Gartner, et al.
Plos Neglected Tropical Diseases|March 20, 2008
Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boostingAudrey Tanghe, Jean-Pierre Dangy, Gerd Pluschke, et al.
Acta Clinica Belgica|April 15, 2016
Serodiagnosis of whooping cough in Belgium: results of the National Reference Centre for Bordetella pertussis anno 2013Sophie Duterme, Raymond Vanhoof, Jean Vanderpas, et al.
Vaccines|September 8, 2015
Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype AntigenNicolas Bruffaerts, Marta Romano, Olivier Denis, et al.
Immunology Letters|February 20, 2002
Culture filtrate specific H-2(b) restricted CD8+ T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptidesOlivier Denis, Vincent Stroobant, Didier Colau, et al.
Infection and Immunity|May 23, 2006
Development of luminescent Mycobacterium avium subsp. paratuberculosis for rapid screening of vaccine candidates in miceValérie Rosseels, Virginie Roupie, Denise Zinniel, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Vaccines|May 13, 2016
A Belgian Serosurveillance/Seroprevalence Study of Diphtheria, Tetanus and Pertussis Using a Luminex xMAP Technology-Based PentaplexRaissa Nadège Caboré, Denis Piérard, Kris Huygen
Immunogenetics|May 29, 2007
Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12Youssef Fikri, Jean Nyabenda, Jean Content, et al.
Vaccine|September 20, 2005
Evaluation of the immunogenicity of pBudCE4.1 plasmids encoding mycolyl-transferase Ag85A and phosphate transport receptor PstS-3 from Mycobacterium tuberculosisMarta Romano, Virginie Roupie, Marie Hamard, et al.
Annals of the New York Academy of Sciences|January 3, 2006
Novel bacterial delivery system with attenuated Salmonella typhimurium carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse modelShreemanta K Parida, Kris Huygen, Bernhard Ryffel, et al.
Infection and Immunity|February 28, 2007
A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in miceAudrey Tanghe, Pierre-Yves Adnet, Tatiana Gartner, et al.
Plos Neglected Tropical Diseases|March 20, 2008
Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boostingAudrey Tanghe, Jean-Pierre Dangy, Gerd Pluschke, et al.
Acta Clinica Belgica|April 15, 2016
Serodiagnosis of whooping cough in Belgium: results of the National Reference Centre for Bordetella pertussis anno 2013Sophie Duterme, Raymond Vanhoof, Jean Vanderpas, et al.
Vaccines|September 8, 2015
Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype AntigenNicolas Bruffaerts, Marta Romano, Olivier Denis, et al.
Immunology Letters|February 20, 2002
Culture filtrate specific H-2(b) restricted CD8+ T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptidesOlivier Denis, Vincent Stroobant, Didier Colau, et al.
Infection and Immunity|May 23, 2006
Development of luminescent Mycobacterium avium subsp. paratuberculosis for rapid screening of vaccine candidates in miceValérie Rosseels, Virginie Roupie, Denise Zinniel, et al.
Pageof 11